Restatement of Previously Filed Financial Statements (Tables)

12 Months Ended

Dec. 31, 2023

Error Corrections and Prior Period Adjustments Restatement [Line Items]

Schedule of Error Corrections and Prior Period Adjustments

The following table presents the impact of correcting the errors on the affected line items of our consolidated balance sheet as of December 31, 2022:

	December 31, 2022
	As Reported		Adjustments			As Revised
	(In thousands)
Trade receivables, net	$	91,504	$	(643	)	$	90,861
Other current assets		34,359		(1,921	)		32,438
Total current assets		752,588		(2,564	)		750,024
Total assets		972,515		(2,564	)		969,951
Total stockholders’ equity		874,916		(2,564	)		872,352

The following table presents the impact of correcting the errors on the affected line items of our consolidated statement of income (loss) for the twelve months ended December 31, 2022:

	Twelve months ended December 31, 2022
	As Reported		Adjustments			As Revised
	(In thousands, except per share data)
Total revenues	$	362,070	$	(146	)	$	361,924
Restructuring and other charges		11,443		1,921			13,364
Operating income		2,521		(2,067	)		454
Income before income taxes		6,770		(2,067	)		4,703
Net income (loss)		443		(2,067	)		(1,624	)
Net income (loss) per common share:
Basic		0.01		(0.06	)		(0.05	)
Diluted		0.01		(0.06	)		(0.05	)

The following table presents the impact of correcting the errors on the affected line items of our consolidated balance sheet as of December 31, 2021:

	December 31, 2021
	As Reported		Adjustments			As Revised
	(In thousands)
Trade receivables, net	$	100,987	$	(497	)	$	100,490
Total current assets		745,549		(497	)		745,052
Total assets		1,010,426		(497	)		1,009,929
Total stockholders' equity		897,108		(497	)		896,611

The following table presents the impact of correcting the errors on the affected line items of our consolidated statement of income (loss) for the twelve months ended December 31, 2021:

	Twelve months ended December 31, 2021
	As Reported			Adjustments			As Revised
	(In thousands, except per share data)
Total revenues	$	322,945		$	(497	)	$	322,448
Operating income (loss)		(124,838	)		(497	)		(125,335	)
Income (loss) before income taxes		(125,050	)		(497	)		(125,547	)
Net income (loss)		(127,996	)		(497	)		(128,493	)
Net income (loss) per common share:
Basic		(3.62	)		(0.01	)		(3.63	)
Diluted		(3.62	)		(0.01	)		(3.63	)

Previously Reported

Error Corrections and Prior Period Adjustments Restatement [Line Items]

Schedule of Error Corrections and Prior Period Adjustments

The following table presents the impact of correcting the errors on the affected line items of our consolidated statement of income (loss) for the twelve months ended December 31, 2021:

	Twelve months ended December 31, 2021
	As Reported			Adjustments			As Restated
	(In thousands, except per share data)
Total Cost of sales	$	242,356		$	66,910		$	309,266
Restructuring and other charges		78,933			(66,910	)		12,023
Income (loss) before income taxes		(125,547	)		-			(125,547	)
Net income (loss)		(128,493	)		-			(128,493	)
Net income (loss) per common share:
Basic		(3.63	)		-			(3.63	)
Diluted		(3.63	)		-			(3.63	)